Adonis Guancia, MD

Results 1 - 9 of 9
Public Title Project Description Modified
A Phase III Randomised, Double-Blind, Parallel Group, Multicentre Study to Compare the Efficacy, Saf . . . The Sponsor plans to conduct the Phase III study prior to the completion of the Phase I study becaus . . . 24 Oct 2018 03:38:53
A Randomized Phase 2A/2B, Multicenter Study to Compare the Efficacy and Safety of ASLAN001 in Combin . . . This is an open-label, randomized, parallel group Phase 2A/2B study to evaluate the clinical activit . . . 10 Aug 2016 01:37:55
A multicenter, randomized, double-blind Phase III trial to evaluate efficacy and safety of BI 695502 . . . This is a Phase III, randomized, double-blind, multicenter, active comparator, parallel two-arm tria . . . 06 Mar 2018 10:44:53
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy,  Safety, a . . . This is a phase 3, multi-center, randomized, double-blind, parallel-group study to evaluate the effi . . . 24 Oct 2018 03:33:31
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 3 Study of Weekly Paclitaxel with . . . This is a multinational, randomized, multicenter, double-blind, placebo-controlled, Phase 3 study in . . . 25 Apr 2018 04:13:04
A Global, Randomised, Phase 3, Open-label Study of REGN2810 (ANTI-PD 1 Antibody) Versus Platinum Bas . . . To assess the safety and efficacy of REGN2810 as first-line treatment in patients with advanced or m . . . 22 Apr 2019 12:45:31
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Bre . . . This is a Phase III, double-blind, randomized, multicenter study to compare the efficacy and to eval . . . 22 Apr 2019 12:54:11
An extension study to provide treatment with Herceptin® or TX05 and assess continued safety and imm . . . This is an extension study for subjects who were treated in the prior TX05/Herceptin neoadjuvant stu . . . 20 Nov 2018 08:47:35
A Multinational, Randomized, Double-blind, Positive-controlled, Parallel Group Clinical Study to Com . . . This study is a multinational, randomized, double-blind, positve-controlled, parallel group study. T . . . 04 Jan 2019 09:27:53

Copyright © One Window Project 2018. All rights reserved.